|
|
| | Plerixafor Impurity Basic information |
| Product Name: | Plerixafor Impurity | | Synonyms: | Plerixafor Impurity 54;1-(4-Methylbenzyl)-1,4,8,11-tetraazacyclotetradecane;1-[(4-Methylphenyl)methyl]-1,4,8,11-Tetraazacyclotetradecane;1,4,8,11-Tetraazacyclotetradecane, 1-[(4-methylphenyl)methyl]-;Pulesafu impurity 45 | | CAS: | 351472-73-6 | | MF: | C18H32N4 | | MW: | 304.47 | | EINECS: | | | Product Categories: | | | Mol File: | 351472-73-6.mol |  |
| | Plerixafor Impurity Chemical Properties |
| Boiling point | 449.0±45.0 °C(Predicted) | | density | 0.945±0.06 g/cm3(Predicted) | | storage temp. | Refrigerator, under inert atmosphere | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Oil | | pka | 10.30±0.20(Predicted) | | color | Colourless |
| | Plerixafor Impurity Usage And Synthesis |
| Uses | 1-(4-Methylbenzyl)-1,4,8,11-tetraazacyclotetradecane is a CXCR4 antagonist that stimulates rapid increase in circulating number of haematopoietic progenitors cells in mice and humans. It also mobilizes haematopoietic progenitor cells from bone marrow through inhibiting CXCL12 binding to CXCR4 receptor in mouse. |
| | Plerixafor Impurity Preparation Products And Raw materials |
|